Article

Congress delays 10.1% fee cut until July

Washington, DC-In the final days of its 2007 session, Congress passed a temporary fix to delay a scheduled 10.1% Medicare fee cut to physicians for 6 months and provided physicians with a positive 0.5% update.

Washington, DC-In the final days of its 2007 session, Congress passed a temporary fix to delay a scheduled 10.1% Medicare fee cut to physicians for 6 months and provided physicians with a positive 0.5% update.

“We are gratified that Congress acted in time to halt the cut. However, we are deeply disappointed that the fix is only temporary, adding to the uncertainty among physicians and Medicare patients,” said H. Dunbar Hoskins Jr., MD, executive vice president, American Academy of Ophthalmology. “We will continue to work to convince Congress on the need for stability and a multi-year solution to this ongoing issue.”

Congressional action at the end of 2007 also included passage of an extension of the expiring incentive payments for rural physicians, including the floor on work geographic adjustment of 1.0 through June 30, and an extension of the bonus for physician quality reporting. In 2008, physicians who voluntary report on quality measures will be eligible for at least a 1.5% bonus on their entire year’s Medicare revenues, the AAO pointed out.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.